Sportradar Group AG (NASDAQ:SRAD) stock fell 5.9% after being identified as a short target in a report from The Bear Cave. The Switzerland-based sports technology company, which specializes in ...

GlaxoSmithKline ( ($GB:GSK) ) has shared an announcement. GlaxoSmithKline (GSK) has announced the purchase of 243,000 of its own ordinary shares ...

On October 31,‍ JPMorgan low‍ered its price target on GSK plc (NYSE:GSK) to 1,440 GBp fro⁠m 1,550 GBp w⁠hile maintaining an ...

Divide‌n‍d investing has been gainin‍g traction among investors not only in th‍e US but across gl​obal ma⁠rkets.

Jefferies London Healthcare Conference 2025 November 19, 2025 4:30 AM ESTCompany ParticipantsTony Wood - Chief Scientific Officer and Head ...

The stock market environment isn't as good as implied by the “regular new highs” booked by the S&P 500 index, as enthusiasm for artificial intelligence has helped investors ignore “tariff chaos,” the ...

ALEC stock plunges after its dementia candidate fails to slow disease progression in a late-stage study, prompting job cuts and a strategic pipeline shift.

Trevi Therapeutics is developing nalbuphine ER (Haduvio) for chronic cough in IPF and RCC, targeting unmet medical needs.

A strong performer already, GSK stock is trading up 44% in 2025, yet its stock remains a good bargain. GSK trades for a ...

GlaxoSmithKline ( ($GB:GSK) ) has shared an announcement. GSK has announced the repurchase of 167,000 of its own shares as part of its ongoing ...